March 12, 2024
1,899
29
1.53%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:57Now PlayingThe UK is looking to purchase as many as 6.3 million vaccines and treatments to protect babies and elderly people against a common respiratory virus as countries race to secure supplies in time for next winter.
The government has put out a tender notice with its planned orders for drugs that are only currently sold by GSK Plc, Pfizer Inc. and AstraZeneca Plc together with Sanofi, suggesting it’s getting ahead of the European Union, which is still scoping out member states’ interest in joint purchases.
The plan is a boon for the drugmakers, which just introduced competing products against respiratory syncytial virus, or RSV, a target that had eluded scientists for decades. The common ailment can sometimes turn deadly — especially in the very young and the elderly — and an influx of patients puts pressure on health systems every winter.
--------
Subscribe to our YouTube channel
Subscribe to Bloomberg Originals
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.